PepsiCo CEO Tackles Weight-Loss Drug Impact and Affordability Amid Market Shifts | MarketWire

PepsiCo CEO Ramon Laguarta details strategies to address weight-loss drug trends and expanding affordability concerns, shaping the company’s 2026 outlook.

Read full article on MarketWire